23andMe on Sunday announced it is offering a new report that purports to users their risk of developing Type 2 diabetes—but some experts say the tests may not be universally applicable, as 23andMe's genetic database is not representative of the entire U.S. population.
Eric Hammond, a nurse in the ED at Johnston Medical Center, on Saturday was allegedly stabbed by Connor Phillip Sullivan, a patient who was waiting to be treated, in today's bite-sized hospital and health industry news from Illinois, North Carolina, and Tennessee.
Two large operators of Blue Cross and Blue Shield health plans on Monday announced that they plan to merge their administrative, management, and other functions to create one combined structure.
ECRI Institute just released its annual list of the 10 biggest patient-safety concerns in 2019, with diagnostic errors topping the list for the second year in a row.
Do you think you understand the full scope of Google's ambitions in health care? Think again. The tech giant's health efforts are more far-reaching and ambitious than nearly anyone understands—but they’re united by these six visions for transforming health care, writes the Daily Briefing's Jackie Kimmell.
FDA on Friday approved Roche's Tecentriq to treat patients with locally advanced or metastatic triple-negative breast cancer who have the PD-L1 molecule that can block T cells from attacking a tumor.
HHS Secretary Alex Azar announced Tuesday that Ned Sharpless, director of the National Cancer Institute, will become the acting commissioner of FDA when FDA commissioner Scott Gottlieb departs.
A CDC report released last week showed U.S. progress on stemming bloodstream Staphylococcus aureus infections slowed from 2012 to 2017, prompting CDC to urge health care providers to recommit to using infection control recommendations.
Print All Daily Briefing Article from
03/13/2019
Share:
Have a Question?
x
Ask our experts a question on any topic in health care by visiting our member portal, AskAdvisory.
